ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "L01B" (138)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
What is an ATC-Code?ATC-Overview
Methotrexate (L01BA01) 9 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IP  Methotrexat Teva Onco 50
mg/2 ml		 8.0625.2010 %Infusion solution: Methotrexatum 50mg / 2mlTeva Pharma AGA / SL / SGG
  IP  Methotrexat Teva Onco 500
mg/20 ml		 52.4773.5010 %Infusion solution: Methotrexatum 500mg / 20mlTeva Pharma AGA / SL / SGG
  IP  Methotrexat Teva Onco
5000 mg/50 ml		 314.54358.5010 %Infusion solution: Methotrexatum 5000mg / 50mlTeva Pharma AGA / SL / SGG
  IPCI Methotrexat Sandoz 5 mg208.2525.4010 %Tablets: Methotrexatum 5 mgSandoz
Pharmaceuticals AG		A / SL / SGG
  IPCI Methotrexat Sandoz 10 mg106.4716.2510 %Tablets: Methotrexatum 10 mgSandoz
Pharmaceuticals AG		A / SL / SGG
  IP  Methotrexat Sandoz 5000 mg50 ml314.54358.5010 %Konzentrat zur Herstellung einer Injektions-/Infusionslösung: MethotrexatumSandoz
Pharmaceuticals AG		A / SL / SGG
  IP  Methotrexat Teva Onco 5
mg/2 ml		 2.997.55k.A.Infusion solution: Methotrexatum 5mg / 2mlTeva Pharma AGAG
  IP  Methotrexat Teva Onco
1000 mg/10 ml		 90.25120.00k.A.Infusion solution: Methotrexatum 1000mg / 10mlTeva Pharma AGAG
  IP  Methotrexat Sandoz 1000 mg10 ml81.00109.40k.A.Konzentrat zur Herstellung einer Injektions-/Infusionslösung: MethotrexatumSandoz
Pharmaceuticals AG		AG
Mercaptopurine (L01BB02) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IPCI Puri-Nethol25 Tablet(s)61.1082.8510 %Tablets: Mercaptopurinum Monohydricum 50 mgIpsen Pharma Schweiz
GmbH		A / SLG
L IPCI Xaluprine 20 mg/ml100 ml253.38292.0010 %Suspension (oral): Mercaptopurinum Monohydricum 20 mg/mlLipomed AGA / SLG
Cladribine (L01BB04) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP  Litak 10Durchstechflasche(n)318.12362.4010 %Injektions- / Infusionslösung: Cladribinum 10mg / 5mlLipomed AGA / SLG
L IP  Litak 105 Durchstechflasche(n)1503.821651.9010 %Injektions- / Infusionslösung: Cladribinum 10mg / 5mlLipomed AGA / SLG
Fludarabine (L01BB05) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP  Fludarabin Accord 25
mg/ml		 135.43163.7010 %Konzentrat zur Herstellung einer Injektions- /Infusionslösung: Fludarabini Phosphas 50mg / 2mlAccord Healthcare AGA / SL / SGG
L IP  Fludarabin-TevaDurchstechflasche(n) à 50 mg135.43163.7010 %Konzentrat zur Herstellung einer Injektions- /Infusionslösung: Fludarabini Phosphas 50mg / 2mlTeva Pharma AGA / SL / SGG
Cytarabine (L01BC01) 8 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IP  Cytosar Solution 100 mg/5 mlDurchstechflasche(n)3.5713.1010 %Injektionslöung: Cytarabinum 100 mgPfizer AGA / SL / SOG
  IP  Cytosar Solution 2 g/20 mlDurchstechflasche(n)54.1975.3510 %Injektionslöung: Cytarabinum 2000 mgPfizer AGA / SL / SOG
     Cytarabine Pharmintraco 500 mgDurchstechflasche(n)k.A.soluzione iniettabile / per infusione: Cytarabinum 500mg / 5mlPharmintraco SaglAG
     Cytarabine Pharmintraco
1000 mg		Durchstechflasche(n)k.A.soluzione iniettabile / per infusione: Cytarabinum 1000mg / 10mlPharmintraco SaglAG
     Cytarabine Pharmintraco
2000 mg		Durchstechflasche(n)k.A.soluzione iniettabile / per infusione: Cytarabinum 2000mg / 20mlPharmintraco SaglAG
     Cytarabine Pharmintraco 500 mg10 Durchstechflasche(n)k.A.soluzione iniettabile / per infusione: Cytarabinum 500mg / 5mlPharmintraco SaglAG
     Cytarabine Pharmintraco
1000 mg		10 Durchstechflasche(n)k.A.soluzione iniettabile / per infusione: Cytarabinum 1000mg / 10mlPharmintraco SaglAG
     Cytarabine Pharmintraco
2000 mg		10 Durchstechflasche(n)k.A.soluzione iniettabile / per infusione: Cytarabinum 2000mg / 20mlPharmintraco SaglAG
Fluorouracil (L01BC02) 30 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IP  Fluorouracil Accord 250
mg/5 ml		 2.9012.4010 %Infusion solution: Fluorouracilum 250mg / 5mlAccord Healthcare AGA / SL / SGG
  IP  Fluorouracil Accord 500
mg/10 ml		 4.2513.8510 %Infusion solution: Fluorouracilum 500mg / 10mlAccord Healthcare AGA / SL / SGG
  IP  Fluorouracil Accord 1000
mg/20 ml		 6.6516.4510 %Infusion solution: Fluorouracilum 1000mg / 20mlAccord Healthcare AGA / SL / SGG
  IP  Fluorouracil Accord 2500
mg/50 ml		 14.9032.6010 %Infusion solution: Fluorouracilum 2500mg / 50mlAccord Healthcare AGA / SL / SGG
  IP  Fluorouracil Accord 5000
mg/100 ml		 26.6045.3510 %Infusion solution: Fluorouracilum 5000mg / 100mlAccord Healthcare AGA / SL / SGG
  IP  Fluorouracil-TevaDurchstechflasche(n) à 500 mg4.3814.0010 %Infusion solution: Fluorouracilum 50 mg/mlTeva Pharma AG● A / SL / SGG
  IP  Fluorouracil-TevaDurchstechflasche(n) à 1000 mg6.8016.6010 %Infusion solution: Fluorouracilum 50 mg/mlTeva Pharma AGA / SL / SGG
  IP  Fluorouracil-TevaDurchstechflasche(n) à 5000 mg27.1845.9510 %Infusion solution: Fluorouracilum 50 mg/mlTeva Pharma AGA / SL / SGG
  IP  Fluorouracil Sandoz 250
mg/5 ml		Durchstechflasche(n)2.9412.4510 %Injection solution: Fluorouracilum 250mg / 5mlSandoz
Pharmaceuticals AG		A / SL / SGG
  IP  Fluorouracil Sandoz 500
mg/10 ml		Durchstechflasche(n)4.2913.9010 %Injection solution: Fluorouracilum 500mg / 10mlSandoz
Pharmaceuticals AG		A / SL / SGG
  IP  Fluorouracil Sandoz 1000
mg/20 ml		Durchstechflasche(n)6.6516.4510 %Injection solution: Fluorouracilum 1000mg / 20mlSandoz
Pharmaceuticals AG		A / SL / SGG
  IP  Fluorouracil Sandoz 5000
mg/100 ml		Durchstechflasche(n)26.6345.4010 %Injection solution: Fluorouracilum 5000mg / 100mlSandoz
Pharmaceuticals AG		A / SL / SGG
  IP  Fluorouracil Labatec 250
mg/5 ml		 2.9712.4510 %Solution injectable/pour perfusion: Fluorouracilum 250mg / 5mlLabatec Pharma SAA / SL / SGG
  IP  Fluorouracil Labatec 500
mg/10 ml		 4.3413.9510 %Solution injectable/pour perfusion: Fluorouracilum 500mg / 10mlLabatec Pharma SAA / SL / SGG
  IP  Fluorouracil Labatec 1000
mg/20 ml		 6.7316.5510 %Solution injectable/pour perfusion: Fluorouracilum 1000mg / 20mlLabatec Pharma SAA / SL / SGG
  IP  Fluorouracil Labatec 5000
mg/100 ml		 26.9145.7010 %Solution injectable/pour perfusion: Fluorouracilum 5000mg / 100mlLabatec Pharma SAA / SL / SGG
  IPCI Efudix20 g26.7845.5510 %Cream: Fluorouracilum 50 mgMEDA Pharmaceuticals
Switzerland GmbH		● A / SLG
  IPCI Tolak 40 mg/g20 g26.7845.5510 %Cream: Fluorouracilum 40 mgPierre Fabre Pharma SAA / SLG
  IP  Fluorouracil-TevaDurchstechflasche(n) à 250 mg3.0012.5010 %Infusion solution: Fluorouracilum 50 mg/mlTeva Pharma AGA / SL / SGG
  IP  Fluorouracil Sandoz 2500
mg/50 ml		Durchstechflasche(n)14.9732.70k.A.Injection solution: Fluorouracilum 2500mg / 50mlSandoz
Pharmaceuticals AG		AG
  IPCI Fluodix Leman 50 mg/g
(5%)		20 gk.A.Cream: Fluorouracilum 50 mgLeman SKL SAAG
  IPCI Tolak 40 mg/g40 gk.A.Cream: Fluorouracilum 40 mgPierre Fabre Pharma SAAG
  IP  Fluorouracil Pharmintraco 250
mg/5 ml		Durchstechflasche(n) à 5 mlk.A.solution pour injection/perfusion: Fluorouracilum 250mg / 5mlPharmintraco SaglAG
  IP  Fluorouracil Pharmintraco 500
mg/10 ml		Durchstechflasche(n) à 10 mlk.A.solution pour injection/perfusion: Fluorouracilum 500mg / 10mlPharmintraco SaglAG
  IP  Fluorouracil Pharmintraco
1000 mg/20 ml		Durchstechflasche(n) à 20 mlk.A.solution pour injection/perfusion: FluorouracilumPharmintraco SaglAG
  IP  Fluorouracil Pharmintraco 250
mg/5 ml		10 1 Durchstechflasche(n) à 5 mlk.A.solution pour injection/perfusion: Fluorouracilum 250mg / 5mlPharmintraco SaglAG
  IP  Fluorouracil Pharmintraco 500
mg/10 ml		10 1 Durchstechflasche(n) à 10 mlk.A.solution pour injection/perfusion: Fluorouracilum 500mg / 10mlPharmintraco SaglAG
  IP  Fluorouracil Pharmintraco
5000 mg/100 ml		Durchstechflasche(n) à 100 mlk.A.solution pour injection/perfusion: FluorouracilumPharmintraco SaglAG
  IP  Fluorouracil Pharmintraco
1000 mg/20 ml		10 1 Durchstechflasche(n) à 20 mlk.A.solution pour injection/perfusion: FluorouracilumPharmintraco SaglAG
  IP  Fluorouracil Pharmintraco
5000 mg/100 ml		10 1 Durchstechflasche(n) à 100 mlk.A.solution pour injection/perfusion: FluorouracilumPharmintraco SaglAG
Gemcitabine (L01BC05) 19 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IP  Gemcitabin Accord 200
mg/2 ml		 18.8036.8510 %Concentrate for infusion: Gemcitabinum 200mg / 2mlAccord Healthcare AGA / SL / SGG
  IP  Gemcitabin Accord 1000
mg/10 ml		 90.25114.4510 %Concentrate for infusion: Gemcitabinum 1000mg / 10mlAccord Healthcare AGA / SL / SGG
  IP  Gemcitabin Accord 2000
mg/20 ml		 172.92204.2510 %Concentrate for infusion: Gemcitabinum 2000mg / 20mlAccord Healthcare AGA / SL / SGG
  IP  Gemcitabin Sandoz 200
mg/5 ml		Flasche(n)19.5237.6010 %Concentrate for infusion: Gemcitabinum 200mg / 5mlSandoz
Pharmaceuticals AG		A / SL / SGG
  IP  Gemcitabin Sandoz 1000
mg/25 ml		Flasche(n)90.25114.4510 %Concentrate for infusion: Gemcitabinum 1000mg / 25mlSandoz
Pharmaceuticals AG		A / SL / SGG
  IP  Gemcitabin Sandoz 2000
mg/50 ml		Flasche(n)172.92204.2510 %Concentrate for infusion: Gemcitabinum 2000mg / 50mlSandoz
Pharmaceuticals AG		A / SL / SGG
  IP  Gemcitabin-Teva liquid 200 mg / 5 ml 19.5237.6010 %Concentrate for infusion: Gemcitabinum 200mg / 5mlTeva Pharma AG● A / SL / SGG
  IP  Gemcitabin-Teva liquid 1 g / 25 ml 90.25114.4510 %Concentrate for infusion: GemcitabinumTeva Pharma AGA / SL / SGG
  IP  Gemcitabin-Teva liquid 2 g / 50 ml 172.92204.2510 %Concentrate for infusion: GemcitabinumTeva Pharma AGA / SL / SGG
  IP  Gemcitabin Accord 1500
mg/15 ml		 k.A.Concentrate for infusion: Gemcitabinum 1500mg / 15mlAccord Healthcare AGAG
  IP  Gemcitabin DRAC 200mgDurchstechflasche(n)k.A.DRAC AGAG
  IP  Gemcitabin DRAC 1gDurchstechflasche(n)k.A.DRAC AGAG
  IP  Gemcitabin DRAC 2gDurchstechflasche(n)k.A.DRAC AGAG
  IP  Gemcitabine Pharmintraco 200 mgDurchstechflasche(n)k.A.Concentrato per soluzione per infusione: Gemcitabinum 200 mgPharmintraco SaglAG
  IP  Gemcitabine Pharmintraco 200 mg10 Durchstechflasche(n)k.A.Concentrato per soluzione per infusione: Gemcitabinum 200 mgPharmintraco SaglAG
  IP  Gemcitabine Pharmintraco 1 gDurchstechflasche(n)k.A.Concentrato per soluzione per infusione: Gemcitabinum 1000 mgPharmintraco SaglAG
  IP  Gemcitabine Pharmintraco 1 g10 Durchstechflasche(n)k.A.Concentrato per soluzione per infusione: Gemcitabinum 1000 mgPharmintraco SaglAG
  IP  Gemcitabine Pharmintraco 2 gDurchstechflasche(n)k.A.Concentrato per soluzione per infusione: Gemcitabinum 2000 mgPharmintraco SaglAG
  IP  Gemcitabine Pharmintraco 2 g10 Durchstechflasche(n)k.A.Concentrato per soluzione per infusione: Gemcitabinum 2000 mgPharmintraco SaglAG
Capecitabine (L01BC06) 12 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IPCI Xeloda 150 mg - T60 Tablet(s)27.3546.0010 %Coated tablets: Capecitabinum 150 mgCheplapharm Schweiz
GmbH		A / SL / SOG
  IPCI Xeloda 500 mg - T120 Tablet(s)185.34216.9510 %Coated tablets: Capecitabinum 500 mgCheplapharm Schweiz
GmbH		A / SL / SOG
  IPCI Capecitabin Accord 150 mg6024.8743.4510 %Coated tablets: Capecitabinum 150 mgAccord Healthcare AGA / SL / SGG
  IPCI Capecitabin Accord 500 mg120168.50199.6510 %Coated tablets: Capecitabinum 500 mgAccord Healthcare AGA / SL / SGG
  IPCI Capecitabin-Teva 150 mg60 Tablet(s)24.8743.4510 %Coated tablets: Capecitabinum 150 mgTeva Pharma AGA / SL / SGG
  IPCI Capecitabin-Teva 500 mg120 Tablet(s)168.50199.6510 %Coated tablets: Capecitabinum 500 mgTeva Pharma AGA / SL / SGG
  IPCI Capecitabin Helvepharm 150 mg60k.A.Coated tablets: Capecitabinum 150 mgHelvepharm AGAG
  IPCI Capecitabin Helvepharm 500 mg120k.A.Coated tablets: Capecitabinum 500 mgHelvepharm AGAG
     Capecitabin Zentiva 150 mg60k.A.Coated tablets: Capecitabinum 150 mgHelvepharm AGAG
     Capecitabin Zentiva 150 mg60k.A.Coated tablets: Capecitabinum 150 mgHelvepharm AGAG
     Capecitabin Zentiva 500 mg120k.A.Coated tablets: Capecitabinum 500 mgHelvepharm AGAG
     Capecitabin Zentiva 500 mg120k.A.Coated tablets: Capecitabinum 500 mgHelvepharm AGAG
Azacitidine (L01BC07) 13 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
LSIPIP  Vidaza 100 mgDurchstechflasche(n)312.78350.7520 %Lyophilisat pour suspension injectable: Azacitidinum 100 mgBristol-Myers Squibb SAA / SL / SOG
L IP  Azacitidin Accord 100 mg 224.25259.9510 %Powder for injection suspension: Azacitidinum 100 mgAccord Healthcare AGA / SL / SGG
L IP  Azacitidin Ideogen 100 mg 189.00223.7510 %Powder for injection suspension: Azacitidinum 100 mgIdeogen AGA / SL / SGG
L IP  Azacitidin Sandoz 100 mg 224.25259.9510 %Powder for injection suspension: Azacitidinum 100 mgSandoz
Pharmaceuticals AG		A / SL / SGG
L IP  Azacitidin Spirig HC 100 mg 224.25259.9510 %Powder for injection suspension: Azacitidinum 100 mgSpirig HealthCare AGA / SL / SGG
L IP  Azacitidin Stada 100 mg 218.38253.9010 %Powder for injection suspension: Azacitidinum 100 mgSpirig HealthCare AGA / SL / SGG
L IP  Azacitidin Stada 150 mg 304.64347.7510 %Powder for injection suspension: Azacitidinum 150 mgSpirig HealthCare AGA / SL / SGG
L IP  Azacitidin Viatris 100 mg 224.25259.9510 %Powder for injection suspension: Azacitidinum 100 mgViatris Pharma GmbHA / SL / SGG
  IPCI Onureg 200 mg7k.A.Coated tablets: Azacitidinum 200 mgBristol-Myers Squibb SAAG
  IPCI Onureg 200 mg14k.A.Coated tablets: Azacitidinum 200 mgBristol-Myers Squibb SAAG
  IPCI Onureg 300 mg7k.A.Coated tablets: Azacitidinum 300 mgBristol-Myers Squibb SAAG
  IPCI Onureg 300 mg14k.A.Coated tablets: Azacitidinum 300 mgBristol-Myers Squibb SAAG
  IP  Azacitidin Accord 150 mg k.A.Powder for injection suspension: Azacitidinum 150 mgAccord Healthcare AGAG
Decitabine (L01BC08) 4 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP  DacogenDurchstechflasche(n)879.81968.3510 %Lyophilisat zur Herstellung eines Konzentrats zur Herstellung einer Infusionslösung: Decitabinum 50 mgJanssen-Cilag AGA / SL / SOG
L IP  Decitabin Accord 50 mg 799.83886.3010 %Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mgAccord Healthcare AGA / SL / SGG
L IP  Decitabin Sandoz 50 mg 799.83886.3010 %Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mgSandoz
Pharmaceuticals AG		A / SL / SGG
L IP  Decitabine Ideogen 50 mg 694.22777.9010 %Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mgIdeogen AGA / SL / SGG
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home